Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 6
2001 1
2002 1
2003 1
2005 1
2006 1
2008 1
2012 1
2016 1
2017 1
2018 1
2022 1
2023 2
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma.
Sturdivant JM, Royalty SM, Lin CW, Moore LA, Yingling JD, Laethem CL, Sherman B, Heintzelman GR, Kopczynski CC, deLong MA. Sturdivant JM, et al. Among authors: delong ma. Bioorg Med Chem Lett. 2016 May 15;26(10):2475-2480. doi: 10.1016/j.bmcl.2016.03.104. Epub 2016 Apr 1. Bioorg Med Chem Lett. 2016. PMID: 27072905
Discovery and Preclinical Development of Novel Intraocular Pressure-Lowering Rho Kinase Inhibitor: Corticosteroid Conjugates.
Sturdivant J, Williams SS, Ina M, Weksler M, McDougal A, Clancy D, deLong MA, Girouard N, Zaretskaia M, Brennan K, Glendenning A, Foley B, Lin CW, White JC, Kopczynski C, Kelly CR. Sturdivant J, et al. Among authors: delong ma. J Ocul Pharmacol Ther. 2023 Mar;39(2):117-127. doi: 10.1089/jop.2022.0129. Epub 2023 Jan 4. J Ocul Pharmacol Ther. 2023. PMID: 36602977
Eyes on Topical Ocular Disposition: The Considered Design of a Lead Janus Kinase (JAK) Inhibitor That Utilizes a Unique Azetidin-3-Amino Bridging Scaffold to Attenuate Off-Target Kinase Activity, While Driving Potency and Aqueous Solubility.
Gordhan HM, Miller ST, Clancy DC, Ina M, McDougal AV, Cutno DK, Brown RV, Lichorowic CL, Sturdivant JM, Vick KA, Williams SS, deLong MA, White JC, Kopczynski CC, Ellis DA. Gordhan HM, et al. Among authors: delong ma. J Med Chem. 2023 Jul 13;66(13):8929-8950. doi: 10.1021/acs.jmedchem.3c00519. Epub 2023 Jun 14. J Med Chem. 2023. PMID: 37314941
N-acylglycine amidation: implications for the biosynthesis of fatty acid primary amides.
Wilcox BJ, Ritenour-Rodgers KJ, Asser AS, Baumgart LE, Baumgart MA, Boger DL, DeBlassio JL, deLong MA, Glufke U, Henz ME, King L 3rd, Merkler KA, Patterson JE, Robleski JJ, Vederas JC, Merkler DJ. Wilcox BJ, et al. Among authors: delong ma. Biochemistry. 1999 Mar 16;38(11):3235-45. doi: 10.1021/bi982255j. Biochemistry. 1999. PMID: 10079066
19 results